See more : S. P. Capital Financing Limited (SPCAPIT.BO) Income Statement Analysis – Financial Results
Complete financial analysis of Hillstream BioPharma, Inc. (HILS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Hillstream BioPharma, Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Polyplex (Thailand) Public Company Limited (PTL.BK) Income Statement Analysis – Financial Results
- Nitto Kohki Co., Ltd. (6151.T) Income Statement Analysis – Financial Results
- Enjoy S.A. (ENJOY.SN) Income Statement Analysis – Financial Results
- Avaya Holdings Corp. (AVYA) Income Statement Analysis – Financial Results
- Kalyani Investment Company Limited (KICL.BO) Income Statement Analysis – Financial Results
Hillstream BioPharma, Inc. (HILS)
About Hillstream BioPharma, Inc.
Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) for the treatment resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-888, a dual Quatramer loaded IMCD inducer coupled with its anthracycline analogue for solid tumors; HSB-510, a targeted bifunctional inhibitory compound in Quatramer with single digit nanomolar IC50 against PI3K-delta and HDAC6, which is also known to downregulate; and HSB-114, an immunotherapeutic agent, which uses its Quatramer technology to deliver tumor necrosis factor-alpha gene into cancer cells. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 3.56M | 2.28M | 1.84M | 847.27K | 368.73K |
General & Administrative | 5.90M | 4.60M | 1.37M | 671.88K | 625.81K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 5.90M | 4.60M | 1.37M | 671.88K | 625.81K |
Other Expenses | 0.00 | 0.00 | 1.83M | -362.49K | -26.46K |
Operating Expenses | 9.46M | 6.88M | 3.21M | 1.52M | 994.54K |
Cost & Expenses | 9.46M | 6.88M | 3.21M | 1.52M | 994.54K |
Interest Income | 152.63K | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | -16.51K | 1.59M | 831.28K | 246.53K | 75.07K |
Depreciation & Amortization | 167.90K | 1.57B | 1.83M | -73.29K | 402.95K |
EBITDA | -9.46M | -6.88M | -1.38M | -1.88M | -1.02M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -9.46M | -6.88M | -3.21M | -1.81M | -1.42M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 136.13K | -1.59M | 1.00M | -609.02K | -101.53K |
Income Before Tax | -9.32M | -8.47M | -2.21M | -2.42M | -1.53M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | 0.00 | 831.28K | -42.67K | -354.33K |
Net Income | -9.32M | -8.47M | -3.04M | -2.37M | -1.17M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -7.14 | -0.75 | -0.30 | -0.21 | -0.10 |
EPS Diluted | -7.14 | -0.75 | -0.30 | -0.21 | -0.10 |
Weighted Avg Shares Out | 1.31M | 11.23M | 10.30M | 11.23M | 11.23M |
Weighted Avg Shares Out (Dil) | 1.31M | 11.23M | 10.30M | 11.23M | 11.23M |
ヒルストーン・ネットワークスがガートナーのネットワーク・ファイアウオールのマジック・クアドラントで再びビジョナリーとして評価される
Hillstone Networks wird erneut als Visionär im Gartner Magic Quadrant for Network Firewalls anerkannt
Hillstone Networks ha ottenuto di nuovo da Gartner il riconoscimento Visionary nel Magic Quadrant for Network Firewalls
Hillstone Networks à nouveau reconnu comme un visionnaire dans le Magic Quadrant de Gartner pour les pares-feux de réseau
Penny Stocks To Buy Now? 10 Stocks Under $1 To Watch
7 Hot Penny Stocks Under $1 To Watch This Week
Hillstream BioPharma to Present at the RHK Capital Disruptive Growth Conference on December 5-6, 2022
Hillstream BioPharma, Inc. to Present at Upcoming Investor Conferences
Penny Stocks To Watch: Why EVFM, AGRX, CYBN, HILS & AFIB Stock Are Moving
Why Hillstream BioPharma Shares Are Trading Higher Today?
Source: https://incomestatements.info
Category: Stock Reports